P8W0 Stock Chart & Stats
€4.58
€0.04(0.90%)
At close: 4:00 PM EDT
€4.58
€0.04(0.90%)
Day’s Range― - ―
52-Week Range€3.66 - €4.70
Previous CloseN/A
Volume0.00
Average Volume (3M)1.00
Market Cap
€1.53B
Enterprise Value€1.22B
Total Cash (Recent Filing)€70.82M
Total Debt (Recent Filing)€18.88M
Price to Earnings (P/E)14.1
Beta0.28
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.27
Shares Outstanding347,126,280
10 Day Avg. Volume0
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)1.02
Price to Sales (P/S)113.12
P/FCF Ratio-1.83K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a substantial equity cushion give the trust financial resilience and flexibility. This reduces balance-sheet strain during periods of weak investment performance and limits the need for debt-funded actions, supporting stability over the next several quarters.
Diversified Healthcare ExposureExposure across multiple healthcare subsectors and geographies can reduce reliance on any single company, therapy, or market. This diversified structure supports the trust’s long-term capital-growth objective while preserving access to different sources of healthcare innovation and demand.
Debt ReductionA meaningful reduction in absolute debt strengthens the trust’s already conservative financial position. Lower obligations can preserve more flexibility for portfolio management and reduce the extent to which financing considerations could constrain shareholder returns during volatile investment periods.
Bears Say
Weak Cash GenerationRepeated negative operating cash flow and zero free cash flow indicate weak conversion of reported results into cash. That can reduce internally generated financial flexibility, increase reliance on portfolio movements or non-cash gains, and make shareholder distributions less supported by recurring cash generation.
Volatile Earnings QualityLarge swings between profits and losses make the trust’s reported earnings difficult to treat as a stable recurring base. This volatility can complicate capital planning, weaken confidence in near-term earnings durability, and make future results more dependent on investment outcomes.
Negative Gross ProfitNegative gross profit in the latest period, alongside strong net income and low revenue, reduces confidence in the underlying quality of reported results. The mismatch suggests earnings may not represent a durable operating pattern and warrants caution when assessing forward performance.
Worldwide Healthcare Trust PLC GBP News
P8W0 FAQ
What was Worldwide Healthcare Trust PLC GBP’s price range in the past 12 months?
Worldwide Healthcare Trust PLC GBP lowest stock price was €3.66 and its highest was €4.70 in the past 12 months.
What is Worldwide Healthcare Trust PLC GBP’s market cap?
Worldwide Healthcare Trust PLC GBP’s market cap is €1.53B.
When is Worldwide Healthcare Trust PLC GBP’s upcoming earnings report date?
Worldwide Healthcare Trust PLC GBP’s upcoming earnings report date is Nov 18, 2026 which is in 58 days.
How were Worldwide Healthcare Trust PLC GBP’s earnings last quarter?
Worldwide Healthcare Trust PLC GBP released its earnings results on Jun 05, 2026. The company reported €0.193 earnings per share for the quarter.
Is Worldwide Healthcare Trust PLC GBP overvalued?
According to Wall Street analysts Worldwide Healthcare Trust PLC GBP’s price is currently Overvalued.
Does Worldwide Healthcare Trust PLC GBP pay dividends?
Worldwide Healthcare Trust PLC GBP does not currently pay dividends.
What is Worldwide Healthcare Trust PLC GBP’s EPS estimate?
Worldwide Healthcare Trust PLC GBP’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Worldwide Healthcare Trust PLC GBP have?
Worldwide Healthcare Trust PLC GBP has 347,126,280 shares outstanding.
What happened to Worldwide Healthcare Trust PLC GBP’s price movement after its last earnings report?
Worldwide Healthcare Trust PLC GBP reported an EPS of €0.193 in its last earnings report. Following the earnings report the stock price went up 2.591%.
Which hedge fund is a major shareholder of Worldwide Healthcare Trust PLC GBP?
Currently, no hedge funds are holding shares in DE:P8W0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Worldwide Healthcare Trust PLC GBP
Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.